WeVote
Log In

Bill

Bill

S 230

Relates to the disposition of fetal remains

2025 Regular Session Introduced by Jim Tedisco

Creates a Podiatry Registration Board under Medicine, with joint oversight, public licensing records, and rules aligned to physician standards to boost transparency and discipline.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 230

Summary — S.230 (2025): “An Act enhancing the podiatric profession's registration and oversight”

Note up front: the bill text filed by Senator Paul R. Feeney concerns podiatry board composition, duties and regulation. Metadata in the submission (title referencing fetal remains and a list of federal sponsors) appears inconsistent with the bill text; this summary follows the bill language itself.

Purpose

To revise and strengthen the statutory structure, governance and oversight of the Board of Registration in Podiatry (placed within the Board of Registration in Medicine), increase transparency of podiatric licensure records and complaints, and align podiatry regulatory requirements with those applied to physicians.

Key provisions and changes

  • Creates a Board of Registration in Podiatry within the Board of Registration in Medicine (new sections 12A–12D in Chapter 13):

    • Composition: five members — three podiatrists (each with ≥7 years practice in Massachusetts), one physician (≥7 years practice in Massachusetts), and one public member (subject to G.L. c.13, §9B).
    • Appointment and term: members appointed by the Governor; five-year terms.
    • Conflict restrictions: members may not be connected to a podiatry school or have financial interests in podiatry-related manufacturing/wholesale/retail businesses.
    • Meetings: annual organizational meeting in October, plus at least six additional meetings per year; quorum = three.
    • Compensation: members serve without pay but receive reimbursement for actual, necessary expenses.

  • Rulemaking and oversight:

    • Section 12D: The Board of Registration in Medicine, in consultation with the Commissioner of Public Health, may review/approve regulations proposed by the podiatry board. Proposed regulations are deemed approved unless the medicine board disapproves in writing within 90 days (with reasons).
    • New c.112 §17C: requires the podiatry board to promulgate regulations jointly with the medicine board and in consultation with the Commissioner of Public Health to ensure podiatrists are subject to requirements commensurate with physicians under G.L. c.13 §§5 and 5A–5M. Topics explicitly included: creation and public dissemination of individual profiles and licensure restrictions; disciplinary actions and reports; claims/reports of malpractice; communications with professional organizations; physical and mental examinations; complaint investigations; and other professional conduct/discipline matters.

  • Records and complaints (amendment to c.112 §17A):

    • The board must keep full records and a registry of all persons registered by it; these are public records open to inspection.
    • The board must investigate complaints concerning violations of podiatry statutes and report findings to the appropriate prosecuting officers.
    • The board must make an annual report on the condition of podiatry in the Commonwealth.

Who is affected

  • Podiatrists licensed in Massachusetts (new or existing): potentially more detailed reporting, public profiles, and disciplinary processes aligned with physician standards.
  • Board of Registration in Podiatry and Board of Registration in Medicine: increased joint rulemaking and oversight duties.
  • Commissioner of Public Health: role in consultation on regulations.
  • Patients and the public: increased transparency of licensing and disciplinary information.
  • Employers, professional organizations, and insurers: may be affected by changes in reporting and disclosure practices.

Procedural status & timeline (as provided)

  • Filed: 1/17/2025 (Senate Docket No. 2066). Introduced in Senate: 1/23/2025.
  • Referred to: Committee on Finance (read twice and referred 1/23/2025); also recorded as referred to Consumer Protection & Professional Licensure (2/27/2025) and to Health (1/08/2025 appears twice).
  • House concurred (2/27/2025).
  • Hearing scheduled: 06/02/2025, 1:00–5:00 PM in B-2.

Potential impacts and considerations

  • Aligning podiatry oversight with physician standards likely increases regulatory parity, public access to disciplinary histories, and formal complaint/investigation procedures.
  • May increase administrative/regulatory burden on podiatrists and the podiatry board (new reporting, profile creation, coordination with medicine board).
  • The 90-day “deemed approved” rule could streamline promulgation of podiatry regulations but gives the medicine board a short window to object.
  • The statutory prohibition on board members’ ties to podiatry education or related businesses aims to reduce conflicts of interest.

If you want, I can:
- Produce a side‑by‑side comparison with current law to show exactly what text would be replaced.
- Draft a plain‑language FAQ about how this would change a podiatrist’s obligations.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.